GlassScriptPhysician profile
Antonio M Phillips
NPI 1679684344
$10,465.35
in general payments reported to CMS, 2019-2025
40 companies · $670 in 2025
The $670 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,877 · 2020: $2,527 · 2021: $2,603 · 2022: $447 · 2023: $531 · 2024: $812 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,006 · Travel and Lodging: $6.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,005.88 |
| Travel and Lodging | $6.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,652.17 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $1,192.19 | 2019-2022 | |
| Pfizer INC. | $828.42 | 2019-2021 | |
| Glaxosmithkline, LLC. | $827.51 | 2019-2022 | |
| Novo Nordisk INC | $666.02 | 2019-2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $651.13 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $578.56 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Dexcom, INC. | $429.75 | 2022-2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $368.58 | 2019-2022 | |
| Nevro Corp. | $344.00 | 2022-2024 | Senza |
| Allergan, INC. | $342.40 | 2019-2020 | |
| Astellas Pharma US INC | $328.47 | 2019-2025 | Veozah |
| Sanofi-Aventis U.S. LLC | $239.16 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $237.95 | 2019-2022 | |
| Exact Sciences Corporation | $219.47 | 2023-2025 | Cologuard Collection Kit |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.